163
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Liposome as drug delivery system enhance anticancer activity of iridium (III) complex

, , , , , , , & show all
Pages 342-355 | Received 07 Jul 2020, Accepted 28 Aug 2020, Published online: 21 Sep 2020

References

  • Amos, L.A., 2011. What tubulin drugs tell us about microtubule structure and dynamics. Semin. Cell and developmental biology, 22 (9), 916–926.
  • An, J.J., et al., 2013. The ROS/JNK/ATF2 pathway mediates selenite-induced leukemia NB4 cell cycle arrest and apoptosis in vitro and in vivo. Cell death & disease, 4, e973.
  • Antonsson, B., 2001. Bax and other pro-apoptotic Bcl-2 family “killer-proteins” and their victim the mitochondrion. Cell and tissue research, 306 (3), 347–361.
  • Apel, A., et al., 2009. Autophagy—a double-edged sword in oncology. International journal of cancer, 125 (5), 991–995.
  • Arnandis, T., et al., 2012. Calpains mediate epithelial-cell death during mammary gland involution: mitochondria and lysosomal destabilization. Cell death and differentiation, 19 (9), 1536–1548.
  • Bai, L., et al., 2020. Liposomes encapsulated iridium(III) polypyridyl complexes enhance anticancer activity in vitro and in vivo. Journal of inorganic biochemistry, 205, 111014.
  • Bannunah, A.M., et al., 2014. Mechanisms of nanoparticle internalization and transport across an intestinal epithelial cell model: effect of size and surface charge. Molecular Pharmaceutics, 11 (12), 4363–4373.
  • Birkinshaw, R.W. and Czabotar, P.E., 2017. The BCL-2 family of proteins and mitochondrial outer membrane permeabilisation. Seminars in cell & developmental biology, 72, 152–162.
  • Cao, J.J., et al., 2017. Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(iii) complexes. Chemical science, 8 (1), 631–640.
  • Cao, R., et al., 2013. Membrane localized iridium(III) complex induces endoplasmic reticulum stress and mitochondria-mediated apoptosis in human cancer cells. Journal of medicinal chemistry, 56(9), 3636–3644.
  • Chen, C.X., et al., 2015. Quantification of protein copy number in single mitochondria: the Bcl-2 family proteins. Biosensors & bioelectronics, 74, 476–482.
  • Chen, Q.Y., et al., 2012. Lysosomal membrane permeabilization is involved in curcumin-induced apoptosis of A549 lung carcinoma cells. Molecular and cellular biochemistry, 359 (1–2), 389–398.
  • Costa, A., et al., 2014. The role of reactive oxygen species and metabolism on cancer cells and their microenvironment. Seminar on cancer biology, 25, 23–32.
  • Craene, B.D. and Berx, G., 2013. Regulatory networks defining EMT during cancer initiation and progression. Nature Reviews. Cancer, 13 (2), 97–110.
  • Delft, M.F.V. and Huang, D.C.S., 2006. How the Bcl-2 family of proteins interact to regulate apoptosis. Cell research, 16 (2), 203–213.
  • Ditaranto, K., et al., 2001. Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer’s disease. Neurobiology of disease, 8 (1), 19–31.
  • Ferlay, J., et al., 2015. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International journal of cancer, 136 (5), E359–E386.
  • Fulda, S., 2013. Modulation of mitochondrial apoptosis by PI3K inhibitors. Mitochondrion, 13 (3), 195–198.
  • Galluzzi, L., et al., 2014. Organelle-specific initiation of cell death. Nature cell biology, 16 (8), 728–736.
  • Hanahan, D. and Weinberg, R.A., 2011. Hallmarks of cancer: the next generation. Cell, 144 (5), 646–674.
  • He, M., et al., 2019. Evaluation of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes. New journal of chemistry., 43, 8566–8579.
  • He, M., et al., 2019. Photoinduced anticancer effect evaluation of ruthenium(II) polypyridyl complexes toward human lung cancer A549 cells. Polyhedron, 165, 97–110.
  • Hengartner, M.O., 2000. The biochemistry of apoptosis. Nature, 407 (6805), 770–776.
  • Hockenbery, D.M., 2010. Targeting mitochondria for cancer therapy. Environmental and molecular mutagenesis, 51 (5), 476–489.
  • Johansson, A.C., et al., 2010. Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis: an international journal on programmed cell death, 15 (5), 527–540.
  • Kaasalainen, M., et al., 2012. Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations. International journal of pharmaceutics, 431 (1–2), 230–236.
  • Kanhai, K.M.S., et al., 2018. Glutathione-PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first-in-human study. British journal of clinical pharmacology, 84 (5), 1020–1028.
  • Khan, M.I., et al., 2012. Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. Biomaterials, 33 (5), 1477–1488.
  • Kondo, Y., et al., 2005. The role of autophagy in cancer development and response to therapy. Nature reviews. Cancer, 5 (9), 726–734.
  • Kono, Y., et al., 2017. Development of magnetic anionic liposome/atelocollagen complexes for efficient magnetic drug targeting. Drug delivery, 24 (1), 1740–1749.
  • Li, J.J., et al., 2019. Design, synthesis, and evaluation of fluorine and naphthyridine-based half-sandwich organoiridium/ruthenium complexes with bioimaging and anticancer activity. European journal of medicinal chemistry, 163, 830–839.
  • Li, Y., et al., 2015. Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior. Biomaterials, 41, 1–14.
  • Liao, C.C., et al., 2018. Iridium (III) complex-loaded liposomes as a drug delivery system for lung cancer through mitochondrial dysfunction. International journal of nanomedicine, 13, 4417–4431.
  • Liu, J.P., et al., 2015. Ruthenium(II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents. Biomaterials, 56, 140–153.
  • Liu, Z., et al., 2011. Organometallic half-sandwich iridium anticancer complexes. Journal of medicinal chemistry, 54 (8), 3011–3026.
  • Luzio, J.P., et al., 2007. Lysosomes: fusion and function. Nature Reviews. Molecular cell biology, 8 (8), 622–632.
  • Ma, W.L., et al., 2019. Potential anticancer agent for selective damage to mitochondria or lysosomes: naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes. European journal of medicinal chemistry, 181, 111599.
  • Ma, X.W., et al., 2012. Single-walled carbon nanotubes alter cytochrome c electron transfer and modulate mitochondrial function. ACS nano, 6, 0486–10496.
  • Marzano, C., et al., 2006. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand. Journal of medicinal chemistry, 49 (25), 7317–7324.
  • Maucort-Boulch, D., et al., 2018. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. International journal of cancer, 142 (12), 2471–2477.
  • Patil, S., et al., 2007. Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials, 28 (31), 4600–4607.
  • Peng, W., et al., 2020. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents. Journal of inorganic biochemistry, 203, 110909.
  • Rahib, L., et al., 2014. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer research, 74 (11), 2913–2921.
  • Rottenberg, H. and Hoek, J.B., 2017. The path from mitochondrial ROS to aging runs through the mitochondrial permeability transition pore. Aging cell, 16 (5), 943–955.
  • Salum, L.B., et al., 2015. N-(1'-naphthyl)-3,4,5-trimethoxybenzohydrazide as microtubule destabilizer: synthesis, cytotoxicity, inhibition of cell migration and in vivo activity against acute lymphoblastic leukemia. European journal of medicinal chemistry, 96, 504–518.
  • See, E., et al., 2014. Physicochemical characterization of asulacrine towards the development of an anticancer liposomal formulation via active drug loading: stability, solubility, lipophilicity and ionization. International journal of pharmaceutics, 473 (1-2), 528–535.
  • Segawa, K. and Nagata, S., 2015. An apoptotic ‘Eat Me’ signal: phosphatidylserine exposure. Trends in cell biology, 25 (11), 639–650.
  • Song, G., et al., 2012. Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs. Journal of liposome research, 3, 177–192.
  • Song, X.D., et al., 2017. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents. European journal of medicinal chemistry, 138, 246–254.
  • Souza, R.A.D., et al., 2010. Antimycobacterial and antitumor activities of palladium(II) complexes containing isonicotinamide (isn): x-ray structure of trans-[Pd(N3)2(isn)2. European Journal of medicinal chemistry, 45 (11), 4863–4868.
  • Sprouse, S., et al., 1984. Photophysical effects of metal-carbon σ bonds in ortho-metalated complexes of Ir(III) and Rh(III). Journal of the American chemical society, 106, 6647–6653.
  • Szoka, F. and Papahadjopoulos, D., 1978. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proceedings of the national academy of sciences of the United States of America, 75 (9), 4194–4198.
  • Tian, C., et al., 2019. Design and synthesis of (2-(phenylamino)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone analogues as potent anti-tubulin polymerization agents. European journal of medicinal chemistry, 183, 111679.
  • Tian, Z.Z., et al., 2018. Lysosome-targeted chemotherapeutics: half-sandwich ruthenium(II) complexes that are selectively toxic to cancer cells. Inorganic chemistry, 57 (17), 10498–10502.
  • Torre, L.A., et al., 2015. Global cancer statistics, 2012. CA: a cancer journal for clinicians, 65 (2), 87–108.
  • Tsujimoto, Y., 2003. Cell death regulation by the Bcl-2 protein family in the mitochondria. Journal of cellular physiology, 195 (2), 158–167.
  • Vermeulen, K., et al., 2003. Cell cycle and apoptosis. Cell proliferation, 36 (3), 165–175.
  • Vernooy, S.Y., et al., 2000. Cell death regulation in drosophila: conservation of mechanism and unique insights. The journal of cell biology, 150 (2), F69–F75.
  • Wang, Y.J., et al., 2018. The induction of apoptosis in BEL-7402 cells by an iridium(III) complex though lysosome-mitochondria pathway. Polyhedron, 156, 320–331.
  • Xiao, K., et al., 2011. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials, 32 (13), 3435–3446.
  • Xiao, S.Y., et al., 2019. Nanomedicine – advantages for their use in rheumatoid arthritis theranostics. Journal of controlled release, 316, 302–316.
  • Xie, Q., et al., 2018. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect. European Journal of Pharmaceutics and Biopharmaceutics: official journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik e.V, 122, 87–95.
  • Xue, Z.Q., et al., 2010. Platinum(II) compounds bearing bone-targeting group: synthesis, crystal structure and antitumor activity. Chemical communications (Cambridge, England)), 46 (8), 1212–1214.
  • Yan, H.H., et al., 2018. Imaging tiny hepatic tumor xenografts via endoglin-targeted paramagnetic/optical nanoprobe. ACS applied materials & interfaces, 10 (20), 17047–17057.
  • Yi, Q.Y., et al., 2019. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes. Journal of biological inorganic chemistry: a publication of the society of biological inorganic chemistry, 24 (2), 151–169.
  • Zhang, D.Y., et al., 2017. Graphene oxide decorated with Ru(II)-polyethylene glycol complex for lysosome-targeted imaging and photodynamic/photothermal therapy. ACS applied materials & interfaces, 9 (8), 6761–6771.
  • Zhang, L.X., et al., 2019a. Design, synthesis, and anticancer effect studies of Iridium(III) polypyridyl complexes against SGC-7901 cells. Molecules, 24, 3129.
  • Zhang, W.Y., et al., 2019b. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system. European journal of medicinal chemistry, 178, 390–400.
  • Zhou, X.T., et al., 2015. Nanostructured lipid carriers used for oral delivery of oridonin: An effect of ligand modification on absorption. International journal of pharmaceutics, 479 (2), 391–398.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.